These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13268347)

  • 1. Inhibition of conversion of fibrinogen to fibrin by abnormal proteins in multiple myeloma.
    FRICK PG
    Am J Clin Pathol; 1955 Nov; 25(11):1263-73. PubMed ID: 13268347
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis and changes in fibrinogen in multiple myeloma.
    SIRRIDGE MS; BOWMAN KS; GARBER PE
    AMA Arch Intern Med; 1958 Mar; 101(3):630-5. PubMed ID: 13507745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of fibrinogen conversion during myeloma].
    LARRIEU MJ; BEAUMONT JL; CAEN J; SELIGMANN M; BERNARD J
    Rev Fr Etud Clin Biol; 1958 Jun; 3(6):617-21. PubMed ID: 13591855
    [No Abstract]   [Full Text] [Related]  

  • 4. Gamma globulin inhibition of fibrin clot formation.
    Davey FR; Gordon GB; Boral LI; Gottlieb AJ
    Ann Clin Lab Sci; 1976; 6(1):72-7. PubMed ID: 1247286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
    Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
    Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal fibrin ultrastructure, polymerization, and clot retraction in multiple myeloma.
    Lackner H; Hunt V; Zucker MB; Pearson J
    Br J Haematol; 1970 Jun; 18(6):625-36. PubMed ID: 5428623
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.
    O'Kane MJ; Wisdom GB; Desai ZR; Archbold GP
    J Clin Pathol; 1994 Mar; 47(3):266-8. PubMed ID: 8163700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The conversion of fibrinogen to fibrin. IV. Reversible inhibition of the reaction.
    SHULMAN S
    Arch Biochem; 1951 Feb; 30(2):353-71. PubMed ID: 14811507
    [No Abstract]   [Full Text] [Related]  

  • 9. An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma.
    Panzer S; Thaler E
    Haemostasis; 1993; 23(1):69-76. PubMed ID: 8477911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired fibrin formation in a patient with multiple myeloma presenting the "gelation" phenomenon.
    Ideguchi H; Suehiro T; Ohike M; Ohishi H; Katsuno M; Nishimura J; Ibayashi H
    Nihon Ketsueki Gakkai Zasshi; 1988 Feb; 51(1):109-17. PubMed ID: 3389056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma fibrinogen in multiple sclerosis].
    PERSSON I
    Nord Med; 1952 Mar; 47(10):310-2. PubMed ID: 14911005
    [No Abstract]   [Full Text] [Related]  

  • 12. A POLAR INTERMEDIATE IN THE CONVERSION OF FIBRINOGEN TO FIBRIN MONOMER.
    HASCHEMEYER AE
    Biochemistry; 1963; 2():851-8. PubMed ID: 14075125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nature of conversion of fibrinogen into fibrin].
    BELITSER VA; KHDOROVA EL
    Biokhimiia; 1952; 17(6):676-83. PubMed ID: 13081673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Time of fibrinogen-fibrin conversion in normal blood clotting].
    BRAUNSTEINER H; REIMER EE
    Wien Z Inn Med; 1950 Oct; 31(10):375-7. PubMed ID: 14798856
    [No Abstract]   [Full Text] [Related]  

  • 15. Action of serotonin on conversion of fibrinogen to fibrin.
    KATO L; GOZSY B
    Am J Physiol; 1958 Oct; 195(1):66-8. PubMed ID: 13583123
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibility of interference of the fibrinogen-fibrin conversion mechanism by small doses of heparin].
    SCANU A; MANCINI M
    Boll Soc Ital Biol Sper; 1955; 31(1-2):148-51. PubMed ID: 13239848
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of oxidative/nitrative modifications of plasma proteins, selected ROTEM parameters and kinetics of fibrinogen polymerization in patients with multiple myeloma at diagnosis.
    Nowak W; Treliński J; Chojnowski K; Matczak J; Robak M; Misiewicz M; Nowak P
    Med Oncol; 2017 Jan; 34(1):4. PubMed ID: 27900590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SOME KINETIC PROBLEMS IN THE CONVERSION OF FIBRINOGEN TO FIBRIN].
    BARETSKA TV; HRIANUKHINA KO; BELITSER VO
    Ukr Biokhim Zh; 1964; 36():3-13. PubMed ID: 14173734
    [No Abstract]   [Full Text] [Related]  

  • 19. The conversion of fibrinogen to fibrin. XX. Transverse wave propagation and non-Newtonian flow in solutions of intermediate fibrinogen polymers.
    FERRY JD; HELDERS FE
    Biochim Biophys Acta; 1957 Mar; 23(3):569-73. PubMed ID: 13426168
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on blood coagulation. I. Factors involved in the conversion of prothrombin into thrombin and of fibrinogen into fibrin].
    LONG LA; COLPRON G
    Union Med Can; 1961 Jan; 90():22-9. PubMed ID: 13763333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.